Aspergillus spp. antifungal susceptibility to triazoles and Amphotericin B

被引：0
|
作者：
Iatta, R. [1 ]
Puttilli, M. R. [1 ]
Immediato, D. [1 ]
Fracchia, L. [2 ]
Otranto, D. [1 ]
Cafarchia, C. [1 ]
机构：
[1] Univ Bari, Bari, Italy
[2] Univ Piemonte Orientale, Novara, Italy
来源：
MYCOSES | 2015年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
P023
引用
收藏
页码：61 / 61
页数：1
相关论文
共 50 条
  • [31] In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia
    Gheith, Soukeina
    Saghrouni, Fatma
    Bannour, Wadiaa
    Ben Youssef, Yosra
    Khelif, Abderrahim
    Normand, Anne-Cecile
    Piarroux, Renaud
    Ben Said, Moncef
    Njah, Mansour
    Ranque, Stephane
    SPRINGERPLUS, 2014, 3
  • [32] In-vitro activity of voriconazole against Aspergillus spp. And comparison with itraconazole and amphotericin B
    Oakley, KL
    Moore, CB
    Denning, DW
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 42 (01) : 91 - 94
  • [33] In-vitro isolation and antifungal susceptibility of amphotericin B-resistant mutants of Aspergillus fumigatus
    Manavathu, EK
    Alangaden, GJ
    Chandrasekar, PH
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1998, 41 (06) : 615 - 619
  • [34] A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility
    K. L. Mortensen
    H. K. Johansen
    K. Fuursted
    J. D. Knudsen
    B. Gahrn-Hansen
    R. H. Jensen
    S. J. Howard
    M. C. Arendrup
    European Journal of Clinical Microbiology & Infectious Diseases, 2011, 30 : 1355 - 1363
  • [35] A prospective survey of Aspergillus spp. in respiratory tract samples: prevalence, clinical impact and antifungal susceptibility
    Mortensen, K. L.
    Johansen, H. K.
    Fuursted, K.
    Knudsen, J. D.
    Gahrn-Hansen, B.
    Jensen, R. H.
    Howard, S. J.
    Arendrup, M. C.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2011, 30 (11) : 1355 - 1363
  • [36] INVITRO ACTIVITIES OF AMPHOTERICIN-B IN COMBINATION WITH 4 ANTIFUNGAL AGENTS AND RIFAMPIN AGAINST ASPERGILLUS SPP
    HUGHES, CE
    HARRIS, C
    MOODY, JA
    PETERSON, LR
    GERDING, DN
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1984, 25 (05) : 560 - 562
  • [37] Isothermal microcalorimetry for antifungal susceptibility testing of Mucorales, Fusarium spp., and Scedosporium spp.
    Tafin, Ulrika Furustrand
    Meis, Jacques F.
    Trampuz, Andrej
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2012, 73 (04) : 330 - 337
  • [38] Antifungal Activity of Essential Oils and Their Constituents against Candida Spp. and Their Effects on Activity of Amphotericin B
    Nozaki, Akiko
    Takahashi, Eizo
    Okamoto, Keinosuke
    Ito, Hideyuki
    Hatano, Tsutomu
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2010, 130 (06): : 895 - 902
  • [39] In vitro interactions between amphotericin B and other antifungal agents and rifampin against Fusarium spp.
    Spader, T. B.
    Venturini, T. P.
    Cavalheiro, A. S.
    Mahl, C. D.
    Mario, D. N.
    Lara, V. M.
    Santurio, J.
    Alves, S. H.
    MYCOSES, 2011, 54 (02) : 131 - 136
  • [40] Amphotericin B and natamycin are not synergistic in vitro against Fusarium and Aspergillus spp. isolated from keratitis
    Lalitha, Prajna
    Shapiro, Brett L.
    Loh, Allison R.
    Fothergill, Annette W.
    Prajna, N. Venkatesh
    Srinivasan, M.
    Oldenburg, Catherine E.
    Quigley, David A.
    Chidambaram, Jaya D.
    McLeod, Stephen D.
    Acharya, Nisha R.
    Lietman, Thomas M.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2011, 95 (05) : 744 - 745
12345